(Inclusive of all Taxes)
Get Free delivery (₹99)
Prescription drugWhats That
25 people bought in last 7 days
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
निर्माता/विपणक :
माइक्रो लैब्स लिमिटेड
सेवन का प्रकार :
मौखिक
वापसी नीति :
वापसी योग्य नहीं
इसके बाद या इस पर समाप्त होता है :
Jan-27
Drug-Drug Interactions
Critical
Severe
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Cilacar-TM 50 Tablet:
Co-administration of Aliskiren with Cilacar-TM 50 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Cilacar-TM 50 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Co-administration of Aliskiren with Cilacar-TM 50 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Cilacar-TM 50 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Cilacar-TM 50 Tablet:
Co-administration of Cilacar-TM 50 Tablet may significantly increase the blood levels of lithium.
How to manage the interaction:
Although there is a possible interaction, Cilacar-TM 50 Tablet can be taken with lithium if prescribed by the doctor. Consult the prescriber if you experience symptoms of lithium intoxication such as drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, or increased urination. Do not discontinue the medication without consulting a doctor.
Co-administration of Cilacar-TM 50 Tablet may significantly increase the blood levels of lithium.
How to manage the interaction:
Although there is a possible interaction, Cilacar-TM 50 Tablet can be taken with lithium if prescribed by the doctor. Consult the prescriber if you experience symptoms of lithium intoxication such as drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, or increased urination. Do not discontinue the medication without consulting a doctor.
TelmisartanPotassium iodide
Severe
How does the drug interact with Cilacar-TM 50 Tablet:
Taking Potassium Iodide with Cilacar-TM 50 Tablet can make high levels of potassium in the blood more likely.
How to manage the interaction:
Although taking Potassium iodide and Cilacar-TM 50 Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Taking Potassium Iodide with Cilacar-TM 50 Tablet can make high levels of potassium in the blood more likely.
How to manage the interaction:
Although taking Potassium iodide and Cilacar-TM 50 Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
How does the drug interact with Cilacar-TM 50 Tablet:
Taking spironolactone with Cilacar-TM 50 Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is a possible interaction, Cilacar-TM 50 Tablet can be taken with spironolactone if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking spironolactone with Cilacar-TM 50 Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is a possible interaction, Cilacar-TM 50 Tablet can be taken with spironolactone if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Cilacar-TM 50 Tablet:
Coadministration of enalapril with Cilacar-TM 50 Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Cilacar-TM 50 Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Coadministration of enalapril with Cilacar-TM 50 Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Cilacar-TM 50 Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Severe
How does the drug interact with Cilacar-TM 50 Tablet:
Co-administration of amiloride with Cilacar-TM 50 Tablet may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm).
How to manage the interaction:
Although there is a possible interaction, amiloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
Co-administration of amiloride with Cilacar-TM 50 Tablet may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm).
How to manage the interaction:
Although there is a possible interaction, amiloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
Severe
How does the drug interact with Cilacar-TM 50 Tablet:
Taking Cilacar-TM 50 Tablet with benazepril may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Cilacar-TM 50 Tablet can be taken with benazepril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medication without consulting a doctor.
Taking Cilacar-TM 50 Tablet with benazepril may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Cilacar-TM 50 Tablet can be taken with benazepril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medication without consulting a doctor.
Severe
How does the drug interact with Cilacar-TM 50 Tablet:
Taking lisinopril with Cilacar-TM 50 Tablet may increase the levels of potassium in blood.
How to manage the interaction:
Although there is a possible interaction, Cilacar-TM 50 Tablet can be taken with lisinopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications.
Taking lisinopril with Cilacar-TM 50 Tablet may increase the levels of potassium in blood.
How to manage the interaction:
Although there is a possible interaction, Cilacar-TM 50 Tablet can be taken with lisinopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications.
Severe
How does the drug interact with Cilacar-TM 50 Tablet:
Taking ramipril with Cilacar-TM 50 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Cilacar-TM 50 Tablet can be taken with ramipril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking ramipril with Cilacar-TM 50 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Cilacar-TM 50 Tablet can be taken with ramipril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
TelmisartanEluxadoline
Severe
How does the drug interact with Cilacar-TM 50 Tablet:
Co-administration of Cilacar-TM 50 Tablet increases levels of eluxadoline by increasing metabolism.
How to manage the interaction:
Taking Cilacar-TM 50 Tablet with Eluxadoline together can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not discontinue any medications without consulting a doctor.
Co-administration of Cilacar-TM 50 Tablet increases levels of eluxadoline by increasing metabolism.
How to manage the interaction:
Taking Cilacar-TM 50 Tablet with Eluxadoline together can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not discontinue any medications without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Product Substitutes
शराब
सावधानी
शराब के सेवन से बचें क्योंकि इससे चक्कर आना बढ़ सकता है।
गर्भावस्था
सावधानी
यदि आप गर्भवती हैं तो कृपया अपने चिकित्सक से परामर्श करें; आपका डॉक्टर तभी दवा लिखेगा जब लाभ जोखिमों से अधिक होंगे।
स्तनपान
सावधानी
यदि आप स्तनपान करा रही हैं तो कृपया अपने चिकित्सक से परामर्श करें; आपका डॉक्टर तय करेगा कि स्तनपान कराने वाली माताओं को Cilacar-TM 50 गोलियाँ 10's दिया जा सकता है या नहीं।
ड्राइविंग
सावधानी
Cilacar-TM 50 गोलियाँ 10's से चक्कर आ सकते हैं, अगर आपको चक्कर आ रहे हैं तो गाड़ी न चलाएं और न ही भारी मशीनरी चलाएं।
लिवर
सावधानी
खुराक समायोजन की आवश्यकता हो सकती है। जिगर की क्षति/यकृत रोग वाले रोगियों में Cilacar-TM 50 गोलियाँ 10's का उपयोग सावधानी के साथ किया जाना चाहिए। कृपया अपने चिकित्सक से परामर्श करें यदि आपको लीवर की समस्या है या इससे संबंधित कोई चिंता है।
गुर्दा
सावधानी
खुराक समायोजन की आवश्यकता हो सकती है। गुर्दे की दुर्बलता/गुर्दे की बीमारी वाले मरीजों में Cilacar-TM 50 गोलियाँ 10's का उपयोग सावधानी के साथ किया जाना चाहिए। अगर आपको किडनी की समस्या है या इससे जुड़ी कोई चिंता है तो कृपया अपने डॉक्टर से सलाह लें।
बच्चे
सावधानी
बच्चों के लिए Cilacar-TM 50 गोलियाँ 10's की सिफारिश नहीं की जाती है क्योंकि सुरक्षा और प्रभावशीलता स्थापित नहीं की गई है।
Have a query?
Customers Also Bought
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
